Alkem Laboratories Limited (NSE:ALKEM)
India
· Delayed Price · Currency is INR 5,460.00
-70.00 (-1.27%)
At close: Mar 9, 2026
Alkem Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 652,825 | 583,680 | 590,890 | 406,055 | 432,909 | 331,171 | Upgrade
|
| Market Cap Growth | 15.69% | -1.22% | 45.52% | -6.20% | 30.72% | 19.09% | Upgrade
|
| Enterprise Value | 629,510 | 555,235 | 573,042 | 400,038 | 427,311 | 330,764 | Upgrade
|
| Last Close Price | 5460.00 | 4834.71 | 4851.79 | 3304.30 | 3475.75 | 2632.45 | Upgrade
|
| PE Ratio | 27.53 | 26.95 | 32.91 | 41.26 | 26.31 | 20.89 | Upgrade
|
| Forward PE | 27.86 | 24.55 | 28.26 | 26.11 | 23.64 | 20.76 | Upgrade
|
| PS Ratio | 4.58 | 4.50 | 4.67 | 3.50 | 4.07 | 3.74 | Upgrade
|
| PB Ratio | 4.73 | 4.69 | 5.52 | 4.30 | 4.89 | 4.38 | Upgrade
|
| P/TBV Ratio | 5.22 | 5.10 | 6.01 | 4.75 | 5.30 | 4.80 | Upgrade
|
| P/FCF Ratio | - | 47.18 | 34.99 | 28.01 | 56.07 | 30.95 | Upgrade
|
| P/OCF Ratio | - | 30.51 | 30.33 | 24.13 | 38.97 | 26.18 | Upgrade
|
| PEG Ratio | 3.36 | 1.79 | 1.07 | 2.67 | 2.26 | 1.10 | Upgrade
|
| EV/Sales Ratio | 4.42 | 4.28 | 4.52 | 3.45 | 4.02 | 3.73 | Upgrade
|
| EV/EBITDA Ratio | 21.96 | 22.55 | 25.73 | 25.17 | 21.24 | 17.27 | Upgrade
|
| EV/EBIT Ratio | 25.33 | 25.80 | 29.13 | 30.32 | 24.51 | 19.76 | Upgrade
|
| EV/FCF Ratio | - | 44.88 | 33.93 | 27.60 | 55.34 | 30.91 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.11 | 0.13 | 0.15 | 0.30 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 0.82 | 0.55 | 0.63 | 0.86 | 1.31 | 0.92 | Upgrade
|
| Debt / FCF Ratio | - | 1.12 | 0.84 | 0.96 | 3.46 | 1.68 | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.22 | -0.27 | 0.03 | 0.15 | 0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.99 | -1.11 | -1.28 | 0.16 | 0.67 | 0.02 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.20 | -1.69 | 0.18 | 1.76 | 0.04 | Upgrade
|
| Asset Turnover | - | 0.78 | 0.86 | 0.83 | 0.83 | 0.83 | Upgrade
|
| Inventory Turnover | - | 1.76 | 1.92 | 1.79 | 1.61 | 1.73 | Upgrade
|
| Quick Ratio | - | 1.69 | 1.68 | 0.94 | 0.70 | 1.01 | Upgrade
|
| Current Ratio | - | 2.76 | 2.61 | 2.36 | 1.76 | 1.92 | Upgrade
|
| Return on Equity (ROE) | - | 19.14% | 17.98% | 11.01% | 20.48% | 23.33% | Upgrade
|
| Return on Assets (ROA) | - | 8.09% | 8.38% | 5.93% | 8.52% | 9.75% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.24% | 21.48% | 20.07% | 10.24% | 17.85% | 19.38% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 15.70% | 17.00% | 13.10% | 18.80% | 21.10% | Upgrade
|
| Earnings Yield | 3.63% | 3.71% | 3.04% | 2.42% | 3.80% | 4.79% | Upgrade
|
| FCF Yield | - | 2.12% | 2.86% | 3.57% | 1.78% | 3.23% | Upgrade
|
| Dividend Yield | 0.81% | 0.93% | 0.82% | 0.76% | 0.98% | 1.14% | Upgrade
|
| Payout Ratio | - | 23.19% | 29.96% | 23.08% | 25.43% | 21.12% | Upgrade
|
| Total Shareholder Return | 0.81% | 0.93% | 0.82% | 0.76% | 0.98% | 1.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.